Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Australia sees more signs of coronavirus spread stabilising

Published 04/03/2020, 09:58 PM
Updated 04/03/2020, 10:00 PM
© Reuters. FILE PHOTO: A man walks in a corridor near a sign with instructions about the coronavirus and social distancing following the implementation of stricter social-distancing and self-isolation rules to limit the spread of the coronavirus disease (COVID-19)

MELBOURNE (Reuters) - Australia on Saturday reported more signs that the spread of the novel coronavirus has been stabilising, as New South Wales (NSW) health authorities defended the disembarking in mid-March of a virus-hit cruise ship.

According to the federal health ministry data, there were 230 new cases of the coronavirus in the 24-hour period to early Saturday in Australia, bringing the total to 5,454 cases.

This suggests the daily increase rate has continued to stay at around 5% in recent days, significantly lower than the 30% jumps seen two weeks ago.

Twenty-eight deaths so far have been related to COVID-19, the disease caused by the virus.

Seven deaths and more than 600 coronavirus cases have come from one cruise ship alone - Carnival (NYSE:CCL) Corp's Ruby Princess, which disembarked in Sydney in March despite health officials knowing of the risk of coronavirus aboard the ship.

NSW Health Minister Brad Hazzard defended criticism of health officials who allowed the ship's more than 2,700 passengers to leave.

"Each of the staff of the chief health officer made the decision made it to the best of their ability," Hazzard told reporters in televised briefing. "And those people are experts in their fields."

Cruise ships are responsible for at around 20% of Australia's coronavirus cases and several remain floating in waters off the coast after being refused entry to ports.

Although the spread of the coronavirus cases has shown signs of slowing, Australia has been strengthened its efforts in the global race to halt the coronavirus pandemic, cases now past 1 million worldwide and fatalities at more than 53,000 fatalities.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's top biosecurity research agency, said on Saturday it has received A$220 million ($132 million) from the government to update its facilities.

On Thursday, Australia's national science agency, which is operated by CSIRO, said it had commenced pre-clinical testing of two potential vaccines at its high-containment biosecurity facility near Melbourne.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.